New Research from the CWMH: Risk of Major Malformations in Infants with Prenatal Exposure to Benzodiazepines
Data from an ongoing pregnancy registry offers reassurance that benzodiazepines do not appear to have major teratogenic effects.
Data from an ongoing pregnancy registry offers reassurance that benzodiazepines do not appear to have major teratogenic effects.
Our data regarding prenatal exposure to BZDs and/or z-drugs and risk of neurodevelopmental outcomes is still sparse.
While we have relatively limited information regarding the prevalence of obsessive-compulsive disorder (OC) during pregnancy and the postpartum period. Previous studies have indicated that women may be more vulnerable to the onset of OCD during [...]
Although we have data on the reproductive safety of various medications used to treat anxiety, many women would understandably prefer to avoid medications when possible. Many women ask about alternative treatments, including dietary supplements, herbal [...]
Over the last few years, the medical community has been using the term perinatal mood and anxiety disorders (PMADs) to describe the spectrum of psychological symptoms women may experience during pregnancy or the postpartum period. [...]
ACOG recommends that clinicians screen women at least once during the perinatal period for anxiety symptoms.
For so many, uncertainty can lead to anxiety.
Early pregnancy loss is common, affecting up to 25% of pregnancies. Studies looking at the emotional consequences of miscarriage have shown that...
When providing information to patients regarding the use of medications during pregnancy, one key element of the decision-making process is an appraisal of the risks associated with untreated psychiatric illness in the mother. While there [...]
Anxiety disorders affect nearly 1 in 5 adults in the United States, and women are about twice as likely as men to suffer from an anxiety disorder at some point in their lifetime. According to [...]